Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

HERBALIFE LTD.
Next earnings Aug 4, 2026 · consensus $0.62 EPS, $1.32B rev
Last earnings +1.1% on 2026-05-06
Conservative balance sheet (liabilities/equity -6.40x).
Sources: SEC EDGAR (CIK 0001180262, latest 10-Q filed 2026-05-06) · EODHD · as of 6/22/2026, 1:53:57 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
Middling fundamentals offset by an attractive price (~32% below fair value) — worth a look on the value angle.
HERBALIFE LTD. shows $5.04B in FY2025 revenue (+0.9% YoY), a 4.5% net margin, and -44.3% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $5.80B | $5.20B | $5.06B | $4.99B | $5.04B |
| Gross profit | $4.56B | $4.03B | $3.87B | $3.89B | $3.92B |
| Operating income | $734M | $545M | $356M | $386M | $481M |
| Net income | $447M | $321M | $142M | $254M | $228M |
| Diluted EPS | $4.13 | $3.23 | $1.42 | $2.50 | $2.20 |
| Net margin | 7.7% | 6.2% | 2.8% | 5.1% | 4.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Last 90 days: 1 open-market buy · 4 sales
| 2026-06-04 | L'Helias Sophie Director | Buy | 1.20K @ $11.31 | $13.6K |
| 2026-05-19 | Hicks Troy Chief Operating Officer | Sell | 10.0K @ $12.32 | $123K |
| 2026-05-18 | Hicks Troy Chief Operating Officer | Sell | 38.4K @ $12.93 | $496K |
| 2026-05-18 | Hicks Troy Chief Operating Officer | Exercise | 17.5K @ $8.31 | $145K |
| 2026-05-18 | Hicks Troy Chief Operating Officer | Tax | 14.6K @ $12.59 | $183K |
| 2026-05-18 | Hicks Troy Chief Operating Officer | Exercise | 65.8K @ $9.58 | $630K |
| 2026-05-18 | Hicks Troy Chief Operating Officer | Tax | 58.1K @ $12.59 | $731K |
| 2026-05-12 | Lamberti Frank Chief Commercial Officer | Sell | 135K @ $13.50 | $1.82M |
| 2026-05-11 | Lamberti Frank Chief Commercial Officer | Sell | 7.94K @ $13.86 | $110K |
| 2026-05-08 | Cloud Lynda Director | Award | 11.9K | |
| 2026-05-08 | Otero Maria Director | Award | 11.9K | |
| 2026-05-08 | Carmona Richard H Director | Award | 11.9K |